GW Pharma (GWPH)
NASDAQ:GWPH
$218.96
$0.00(0.00%)
GWPHGW Pharma
$218.96

GW Pharma Stock Analysis & Ratings

GW Pharma Stock Analysis Overview

Smart Score
1
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The GW Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

GWPH
$218.96

GWPH Stock Stats

Previous Close$218.96
Open$0
Bid0 x 0
Ask0 x 0
Today’s Range$0 - $0
52-Week Range$87.06 - $219.57
VolumeN/A
Average Volume846.99K
Market Cap$6.91B
Beta1.65
P/E Ratio-107.3
EPS-8.17

Company Description

GW Pharma

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Justin David Gover
Employees
1,161
Address
Cambridge

Financials

Currently, no data available
Please return soon as the page is updated accordingly.

P/E Ratio Range

Currently, no data available
Please return soon as the page is updated accordingly.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

GWPH FAQ

What was GW Pharma’s price range in the past 12 months?
GW Pharma lowest stock price was $87.06 and its highest was $219.57 in the past 12 months.
What is GW Pharma’s market cap?
GW Pharma’s market cap is $6.91B.
What is GW Pharma’s price target?
The average price target for GW Pharma is $220.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $220.00 ,the lowest forecast is $220.00. The average price target represents 0.47% Increase from the current price of $218.96.
What do analysts say about GW Pharma?
GW Pharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
When is GW Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GW Pharma’s earnings last quarter?
Currently, no data Available
Is GW Pharma overvalued?
According to Wall Street analysts GW Pharma’s price is currently Undervalued.
Does GW Pharma pay dividends?
GW Pharma does not currently pay dividends.
What is GW Pharma’s EPS estimate?
GW Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GW Pharma have?
GW Pharma has 31,540,000 shares outstanding.
What happened to GW Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GW Pharma?
Among the largest hedge funds holding GW Pharma’s share is Clough Capital Partners L P. It holds GW Pharma’s shares valued at 11M.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis